Matinas BioPharma Holdings, Inc. (MTNB)
NYSEAMERICAN: MTNB · Real-Time Price · USD
0.6321
-0.0319 (-4.80%)
Jun 30, 2026, 2:29 PM EDT - Market open
Matinas BioPharma Holdings Employees
Matinas BioPharma Holdings had 2 employees as of December 31, 2025. The number of employees decreased by 1 or -33.33% compared to the previous year.
Employees
2
Change (1Y)
-1
Growth (1Y)
-33.33%
Revenue / Employee
n/a
Profits / Employee
-$5,614,000
Market Cap
4.05M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2 | -1 | -33.33% |
| Dec 31, 2024 | 3 | -29 | -90.63% |
| Dec 31, 2023 | 32 | -2 | -5.88% |
| Dec 31, 2022 | 34 | 3 | 9.68% |
| Dec 31, 2021 | 31 | 11 | 55.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 52 |
| GeoVax Labs | 19 |
| FibroBiologics | 15 |
| Ensysce Biosciences | 10 |
| Revelation Biosciences | 9 |
| Artelo Biosciences | 7 |
| Galmed Pharmaceuticals | 6 |
| Alzamend Neuro | 6 |
MTNB News
- 3 days ago - Matinas BioPharma receives noncompliance notification from NYSE - TheFly
- 3 days ago - Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance - GlobeNewsWire
- 13 days ago - Matinas BioPharma files $150M mixed securities shelf - TheFly
- 14 days ago - Matinas BioPharma Holdings Registration statement: Registration filing - Filings
- 7 weeks ago - Matinas BioPharma Holdings Quarterly report: Q1 2026 - Filings
- 3 months ago - Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards - GlobeNewsWire
- 3 months ago - Matinas BioPharma Holdings Annual report: Q4 2025 - Filings
- 8 months ago - Matinas BioPharma Holdings Quarterly report: Q3 2025 - Filings